Feedback / Questions
Duexis (famotidine/ibuprofen) - Horizon Therapeutics, Grunenthal
Duexis: Patent protection until 2026
(Horizon Pharma)
-
Sep 27, 2018 -
Investor Presentation
Patent
•
Pain
http://ir.horizon-pharma.com/static-files/a6ed020f-27fc-4b4f-acf3-33db72a2e075
Sep 27, 2018
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious